Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3913]
News [11356]
Articles [47]
Editorials [10]
Conferences [196]
elearning [4]
Comment on the TRIBE-2 study on first and second-line treatment for metastatic...
Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation...
Comment on the TRIBE-2 study on first and second-line treatment for metastatic colorectal cancer ( Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy )
25 Oct 2018
VALENTINO: Maintenance therapy in advanced CRC
Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation...
VALENTINO: Maintenance therapy in advanced CRC ( Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy )
25 Oct 2018
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic...
Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic profiling of tissue and circulating tumour DNA ( Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah )
25 Oct 2018
The Circulating Cell-Free Genome Atlas Study
Dr Minetta C. Liu - Mayo Clinic, Rochester, Minessota
The Circulating Cell-Free Genome Atlas Study ( Dr Minetta C. Liu - Mayo Clinic, Rochester, Minessota )
25 Oct 2018
The standard of care and progress so far with PARP inhibitors for ovarian cancer
Dr Susana Banerjee - The Institute of Cancer Research, London, UK
The standard of care and progress so far with PARP inhibitors for ovarian cancer ( Dr Susana Banerjee - The Institute of Cancer Research, London, UK )
25 Oct 2018
Cardiac events in stage III NSCLC treated in daily clinical practice
Dr Juliette Degens - Academisch Ziekenhuis Maastricht, Maastricht, Netherlands
Cardiac events in stage III NSCLC treated in daily clinical practice ( Dr Juliette Degens - Academisch Ziekenhuis Maastricht, Maastricht, Netherlands )
25 Oct 2018
Ceritinib and ribociclib in ALK-positive NSCLC
Dr Enriqueta Felip - Vall d'Hebron Institute of Oncology (VHIO), Barcelona...
Ceritinib and ribociclib in ALK-positive NSCLC ( Dr Enriqueta Felip - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
24 Oct 2018
Cemiplimab in patients with hepatocellular carcinoma
Dr Michael J. Pishvaian - Georgetown University, Washington, USA
Cemiplimab in patients with hepatocellular carcinoma ( Dr Michael J. Pishvaian - Georgetown University, Washington, USA )
24 Oct 2018
Updates from the EMBRACA trial for advanced breast cancer
Prof Hope Rugo - University of California, San Francisco, USA
Updates from the EMBRACA trial for advanced breast cancer ( Prof Hope Rugo - University of California, San Francisco, USA )
24 Oct 2018
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy
Dr Linda M. Henricks - Netherlands Cancer Institute, Amsterdam, Netherlands
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy ( Dr Linda M. Henricks - Netherlands Cancer Institute, Amsterdam, Netherlands )
24 Oct 2018
Tumour-infiltrating lymphocytes (TILs) as an independent prognostic factor for...
Dr Maria Vittoria Dieci - University of Padua, Padova, Italy
Tumour-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2 positive breast cancer ( Dr Maria Vittoria Dieci - University of Padua, Padova, Italy )
24 Oct 2018
Liquid biopsy as a monitoring tool for the benefit of chemotherapy...
Dr Laura Bonanno - University of Padova, Padova, Italy
Liquid biopsy as a monitoring tool for the benefit of chemotherapy-immunotherapy in aNSCLC ( Dr Laura Bonanno - University of Padova, Padova, Italy )
24 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation